Are you Dr. Tomkovich?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 52 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
901 W Main St
Medical Arts Building
Freehold, NJ 07728Phone+1 732-462-3302Fax+1 732-780-6213
Summary
- Dr. Kenneth Tomkovich, MD is a board certified radiologist in Freehold, New Jersey. He is currently licensed to practice medicine in New Jersey and Colorado. He is affiliated with CentraState Healthcare System and Penn Medicine Princeton Medical Center.
Education & Training
University of ColoradoFellowship, Vascular and Interventional Radiology, 1998 - 1999
Rutgers Health/New Jersey Medical SchoolResidency, Radiology-Diagnostic, 1994 - 1998
Jersey Shore University Medical CenterInternship, Transitional Year, 1993 - 1994- Rutgers New Jersey Medical SchoolClass of 1993
Certifications & Licensure
NJ State Medical License 1995 - 2025
CO State Medical License 1998 - 1999- American Board of Radiology Interventional Radiology and Diagnostic Radiology
Awards, Honors, & Recognition
- Top MD Consumers Checkbook
Publications & Presentations
PubMed
- 2 citationsCryoablation Without Excision for Early-Stage Breast Cancer: ICE3 Trial 5-Year Follow-Up on Ipsilateral Breast Tumor Recurrence.Richard E Fine, Richard C Gilmore, Kenneth R Tomkovich, Jill R Dietz, Michael P Berry
Annals of Surgical Oncology. 2024-10-01 - Cryoablation of Primary Breast Cancer in Patients Ineligible for Clinical Trials: A Multiinstitutional Study.Karim Oueidat, Grayson L Baird, Belinda Barclay-White, Kamilia Kozlowski, Michael J Plaza
AJR. American Journal of Roentgenology. 2024-09-01 - 7 citationsBreast Cancer Cryoablation Fundamentals Past and Present: Technique Optimization and Imaging Pearls.Monica L Huang, Kenneth Tomkovich, Deanna L Lane, Rajani Katta, Rosalind P Candelaria
Academic Radiology. 2023-10-01
Press Mentions
IceCure’s ProSense for Cryoablation Treatment of Breast Tumors Evaluated in Six StudiesOctober 7th, 2024- IceCure's ICE3 5-Year Trial Results Published in the Peer Reviewed Annals of Surgical Oncology Journal: ProSense® Cryoablation Without Excision for Early-Stage, Low-Risk Breast Cancer Demonstrates 96.3% Recurrence Free RateSeptember 24th, 2024
- IceCure's ProSense Featured in Poster Presentation at Radiological Society of North America's 2022 Annual MeetingNovember 30th, 2022
- Join now to see all
Professional Memberships
- Member
